194.81 USD
↘ 0.97 (0.50%)AT CLOSE (11:59 AM EDT)
AstraZeneca PLC
AZNNYSE • USD
195.21
↗ 0.94 (0.48%)
POST MARKET (AS OF 07:01 PM EDT)
Post Market
AS OF 07:01 PM EDT
195.21
↗ 0.94 (0.48%)
Market: OPEN
Open?$196.55
High?$196.65
Low?$194.80
Prev. Close?$195.78
Volume?1.6M
Avg. Volume?1.8M
VWAP?$195.75
Rel. Volume?0.88x
Bid / Ask
Bid?$192.50 × 200
Ask?$199.00 × 200
Spread?$6.50
Midpoint?$195.75
Valuation & Ratios
Market Cap?303.6B
Shares Out?N/A
P/E Ratio?209.25
P/B Ratio?20.44
EPS?$0.94
Dividend?0.77%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?0.87Weak
Quick Ratio?0.72Weak
Cash Ratio?0.33Low
Debt/Equity?1.77High
ValuationRICHLY VALUED
Score33/100
P/E?209.3PRICEY▾
P/B?20.44HIGH▾
P/S?16.76HIGH▾
P/FCF?334.8PRICEY▾
EV/EBITDA?75.5HIGH▾
EV/Sales?17.93HIGH▾
Returns & Efficiency
ROE?9.8%FAIR▾
ROA?2.3%WEAK▾
Cash Flow & Enterprise
FCF?$907.0M
Enterprise Value?$324.9B
News
Profile
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.